PocketEdge
PocketEdge
NewsResearchPortfolioAdvisorsGuidesToolsAI
Ask AI
PocketEdge

Markets, research, advisors, guides, and tools. Understand what is happening, and what to do next.

Explore

  • News
  • Research
  • Advisors
  • Guides
  • Tools
  • Ask AI

© 2026 PocketEdge

PrivacyTermsLegal

Not investment advice. Verify with licensed professionals.

Company research memos

55 hand-built midcap memos. Filter by verdict, industry, or company. Short news desk notes live under News.

Clear
Clear all

Filters

Clear

Verdict

Industry

Company

1 memo of 55

neutral

TATVA · Specialty Chemicals

Tatva Chintan: PTC recovery at a premium trailing multiple

TTM revenue near ₹556 cr; at ₹1,743 base FY27E offers ~2% downside, Neutral on trailing P/E near 78× and ROCE ~7.2%.

25 min · Yesterday